Whereas there were small context-dependent differences, the canonical and bona fide colon cancer WNT-TCF targets AXIN2 and LGR5 were generally repressed at 5μM CAP2 (batch 2). This evidence concerns the gene AXIN2 and malignant colon neoplasm.